“Placebo- Controlled Trial of Pharmaceutical Optimized Lisinopril 10mg (F-5) in Patients with Essential Hypertension for Efficacy & Biochemical Evaluation”, mfm, vol. 25, no. 12, Apr. 2024, Accessed: Nov. 17, 2025. [Online]. Available: https://medicalforummonthly.com/index.php/mfm/article/view/2376